80% of Patients Now Enrolled in Pioneering Drug-Eluting Covered Stent Graft Study NEW ORLEANS, LA, UNITED STATES, September 2, 2025 /⁨EINPresswire.com⁩/ -- Solaris Endovascular, Inc., a growth-stage U.S.-based medical device company specializing in …